European Medical Information Framework for Alzheimer’s Disease (EMIF-AD) was a collaborative initiative aimed to accelerate Alzheimer’s disease research by providing access to large-scale data resources. It aims to address challenges faced in Alzheimer’s disease research by facilitating data sharing and collaboration among researchers, clinicians, and industry partners. By pooling and harmonizing data from various sources, EMIF-AD aimed to improve understanding of Alzheimer’s disease, identify potential biomarkers, and explore novel therapeutic targets. EMIF-AD includes a variety of data types, such as clinical data, genetic data, biomarker data, and epidemiological data. The project was a part of the broader European Medical Information Framework (EMIF).
The data generated in the context of the EMIF-AD MBD study is available upon request after approval of the research question by all parent cohorts and the EMIF-AD team. Data requests can be submitted via the EMIF-AD Catalogue (https://emif-catalogue.eu).
View Resource